Icosavax, Inc. Profile Avatar - Palmy Investing

Icosavax, Inc.

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipel…

Biotechnology
US, Seattle [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Icosavax, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ICVX's Analysis
CIK: 1786255 CUSIP: 45114M109 ISIN: US45114M1099 LEI: - UEI: -
Secondary Listings
ICVX has no secondary listings inside our databases.